Renowned neuroscientist Dame Uta Frith cautions that the expanding definition of autism spectrum disorder could be diluting its scientific precision, amid rising diagnosis rates and ongoing debates over classification boundaries.
Dame Uta Frith, one of the key figures in modern autism research, has warned that the concept of autism spectrum disorder may have widened so far that it is losing scientific precision. In a recent opinion piece in the journal Psychological Medicine, the German neuroscientist argued that the sharp rise in diagnoses over recent decades cannot be explained by better recognition alone and may reflect a broader drift towards overdiagnosis.
Frith, an emeritus professor at University College London’s Institute of Cognitive Neuroscience, traced the history of autism from the 1940s, when it described a small group of children with profound difficulties in social interaction, communication and behaviour, to today’s far broader diagnostic framework. She said current criteria can encompass people of any age or intellectual ability if they meet the checklist, which in her view makes the boundary of the condition harder to define and easier to stretch.
Her intervention comes against a backdrop of steeply rising diagnosis rates. In the UK, autism identification has climbed from about 4 cases in 10,000 children in the 1960s to around 1 in 57 schoolchildren now, a rise Frith said goes well beyond what improved screening can account for. Psychology Today, in a recent discussion of her argument, noted that the debate has increasingly focused on whether milder presentations are now being folded into the same category as more disabling forms of autism.
Frith said the increase is being driven by several forces, including greater public awareness, less stigma, self-diagnosis on social media and a growing tendency to frame everyday difficulties in medical terms. She also pointed to research suggesting that children diagnosed early often show clearer developmental and language difficulties, while those identified in adolescence or adulthood are more likely to have average or above-average intelligence and co-existing conditions such as anxiety, depression or attention-deficit hyperactivity disorder.
The distinction matters, she argued, because autism diagnosis shapes not only treatment but identity, access to support and the kind of services people receive. With no biological test or laboratory marker for autism, diagnosis still depends heavily on clinical judgement and personal reporting, which makes the process vulnerable to overlap and ambiguity. Frith also said the growing prominence of “masking” or “camouflaging”, in which some people learn to hide social difficulties, has blurred the line further.
Her warning touches a wider debate in autism research and advocacy. Reviews published in the Journal of Child Psychology and Psychiatry have described how the concept has evolved over the past four decades, while studies indexed by PubMed have noted the difficulties of avoiding both under-identification and over-identification in referrals. At the same time, critics of Frith’s position argue that what she sees as overdiagnosis may also reflect a system that has flattened distinct profiles into a single label, rather than evidence that the spectrum has become meaningless.
Frith acknowledged the value of the neurodiversity movement in reducing stigma and challenging outdated assumptions, but said treating autism purely as a difference risks stripping diagnosis of its clinical purpose. She called for a thorough review of diagnostic guidance and for a move towards more specific subcategories, arguing that clearer distinctions would help direct services to the people who need them most and reduce the risk of misdirected care.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
